These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 15269828)

  • 41. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vector integration and fate in the hemophilia dog liver multiple years after AAV-FVIII gene transfer.
    Batty P; Fong S; Franco M; Sihn CR; Swystun LL; Afzal S; Harpell L; Hurlbut D; Pender A; Su C; Thomsen H; Wilson C; Youssar L; Winterborn A; Gil-Farina I; Lillicrap D
    Blood; 2024 Jun; 143(23):2373-2385. PubMed ID: 38452208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Partial correction of murine hemophilia A with neo-antigenic murine factor VIII.
    Sarkar R; Gao GP; Chirmule N; Tazelaar J; Kazazian HH
    Hum Gene Ther; 2000 Apr; 11(6):881-94. PubMed ID: 10779165
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice.
    Sarkar R; Mucci M; Addya S; Tetreault R; Bellinger DA; Nichols TC; Kazazian HH
    Hum Gene Ther; 2006 Apr; 17(4):427-39. PubMed ID: 16610930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII.
    Scallan CD; Liu T; Parker AE; Patarroyo-White SL; Chen H; Jiang H; Vargas J; Nagy D; Powell SK; Wright JF; Sarkar R; Kazazian HH; McClelland A; Couto LB
    Blood; 2003 Dec; 102(12):3919-26. PubMed ID: 12893764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells.
    Nguyen GN; Everett JK; Kafle S; Roche AM; Raymond HE; Leiby J; Wood C; Assenmacher CA; Merricks EP; Long CT; Kazazian HH; Nichols TC; Bushman FD; Sabatino DE
    Nat Biotechnol; 2021 Jan; 39(1):47-55. PubMed ID: 33199875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system.
    Ohlfest JR; Frandsen JL; Fritz S; Lobitz PD; Perkinson SG; Clark KJ; Nelsestuen G; Key NS; McIvor RS; Hackett PB; Largaespada DA
    Blood; 2005 Apr; 105(7):2691-8. PubMed ID: 15576475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies.
    Shi Q; Wilcox DA; Fahs SA; Weiler H; Wells CW; Cooley BC; Desai D; Morateck PA; Gorski J; Montgomery RR
    J Clin Invest; 2006 Jul; 116(7):1974-82. PubMed ID: 16823491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo dose threshold effect of adenovirus-mediated factor VIII gene therapy in hemophiliac mice.
    Bristol JA; Shirley P; Idamakanti N; Kaleko M; Connelly S
    Mol Ther; 2000 Sep; 2(3):223-32. PubMed ID: 10985953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AAV-mediated gene transfer for hemophilia.
    High KA
    Ann N Y Acad Sci; 2001 Dec; 953():64-74. PubMed ID: 11795424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical gene therapy studies for hemophilia using adeno-associated virus (AAV) vectors.
    Couto LB
    Semin Thromb Hemost; 2004 Apr; 30(2):161-71. PubMed ID: 15118928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Enhancing effect of porcine coagulation factor VIII A1 and A3 domains on secretion of post-translationally spliced human/porcine hybrid coagulation factor VIII].
    Zhu FX; Liu ZL; Qu HG; Chi XY
    Sheng Li Xue Bao; 2010 Aug; 62(4):373-81. PubMed ID: 20717639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.
    Gallo-Penn AM; Shirley PS; Andrews JL; Kayda DB; Pinkstaff AM; Kaloss M; Tinlin S; Cameron C; Notley C; Hough C; Lillicrap D; Kaleko M; Connelly S
    Hum Gene Ther; 1999 Jul; 10(11):1791-802. PubMed ID: 10446919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
    Kang Y; Xie L; Tran DT; Stein CS; Hickey M; Davidson BL; McCray PB
    Blood; 2005 Sep; 106(5):1552-8. PubMed ID: 15886327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient generation and amplification of high-capacity adeno-associated virus/adenovirus hybrid vectors.
    Gonçalves MA; van der Velde I; Janssen JM; Maassen BT; Heemskerk EH; Opstelten DJ; Knaän-Shanzer S; Valerio D; de Vries AA
    J Virol; 2002 Nov; 76(21):10734-44. PubMed ID: 12368316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strategies for improving the transduction efficiency of single-stranded adeno-associated virus vectors in vitro and in vivo.
    Jayandharan GR; Zhong L; Li B; Kachniarz B; Srivastava A
    Gene Ther; 2008 Sep; 15(18):1287-93. PubMed ID: 18496572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.
    VandenDriessche T; Vanslembrouck V; Goovaerts I; Zwinnen H; Vanderhaeghen ML; Collen D; Chuah MK
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10379-84. PubMed ID: 10468616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors.
    Flageul M; Aubert D; Pichard V; Nguyen TH; Nowrouzi A; Schmidt M; Ferry N
    J Gene Med; 2009 Aug; 11(8):689-96. PubMed ID: 19455564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correction of bleeding diathesis without liver toxicity using arenaviral-pseudotyped HIV-1-based vectors in hemophilia A mice.
    Park F
    Hum Gene Ther; 2003 Oct; 14(15):1489-94. PubMed ID: 14577928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.